Last autumn, a portfolio manager gazed at a glowing spreadsheet on her Bloomberg terminal on a soggy morning in London. The figures appeared to be correct. stable margins. Cash flow is unaffected. However, the ESG team quietly added a new column titled “PFAS Exposure: Under Review.” It’s difficult to ignore how that phrase, which has a tone that borders on bureaucratic, now carries the weight of asbestos in the 1980s.
In the past, per- and polyfluoroalkyl compounds—also referred to as forever chemicals—were dismissed as unimportant details in sustainability reports. They improved the effectiveness of firefighting foam, made jackets waterproof, and made frying pans slick. Their tenacity led to the creation of billion-dollar product lines. Extreme persistence, which made PFAS commercially irresistible, may have also made them financially explosive, causing them to build up on company balance sheets in addition to in rivers and bloodstreams.
| Category | Details |
|---|---|
| Chemical Group | Per- and Polyfluoroalkyl Substances (PFAS) |
| Common Name | “Forever Chemicals” |
| Major Corporate Cases | 3M, DuPont, Chemours |
| Landmark Settlement | 3M agreed to up to $12.5 billion (2023) over water contamination claims |
| Regulatory Focus (UK) | Environmental Improvement Plan 2025 (under Environment Act 2021) |
| Primary Risk Areas | Water contamination, litigation, supply chain exposure, disclosure liability |
| ESG Relevance | Environmental contamination, governance failures, shareholder risk |
| Reference | US Environmental Protection Agency – PFAS Overview: https://www.epa.gov/pfas |
The reckoning in the U.S. has been direct. In 2023, 3M, a well-known Minnesota company known for its N95 masks and Post-it Notes, consented to pay up to $12.5 billion to resolve claims regarding tainted drinking water. It almost seems abstract because of how big the figure is. However, the results translate into treatment facilities, bottled water, and uncomfortable town hall meetings in towns where municipal wells tested positive. It appears that investors think the worst is already priced in. Whether they are correct or not is still up for debate.
The ESG overlay distinguishes PFAS from previous pollution scandals. Environmental risk now forms the core of capital allocation and is no longer a footnote. Pension boards require climate transition plans, asset managers promote funds as “sustainable,” and disclosure regulations are becoming more stringent. It seems as though PFAS have gotten past that framework, demonstrating how unfinished ESG screens can be when they concentrate on carbon but ignore substances that subtly seep into aquifers.
The pressure is only now starting to affect the UK. Corporate liabilities have changed as a result of American class actions, but the litigation environment in Britain is still disjointed. Regulators are working on the Environmental Improvement Plan 2025, and law firms have begun looking into contamination near industrial sites. It’s odd to think about how many invisible substances flow beneath the Thames when you’re strolling past it on a gloomy afternoon and watching barges pass slowly beneath Waterloo Bridge. Landowners, manufacturers, and water utilities are increasingly looking at exposure maps.
Directors now have to deal with a practical issue. Across continents, supply chains extend. PFAS can conceal themselves in three-tiered components such as industrial sealants, waterproof membranes, and coated textiles. It takes a lot of work to map that risk, including supplier questionnaires, spreadsheets, and sometimes awkward phone calls. Executives have some doubts about the extent to which regulators will go. However, the “polluter pays” theory, which is becoming popular in policy circles, implies that liabilities might not stay theoretical.
Investors in ESG are responding differently. Similar to how they did with coal, some funds are discreetly pulling out of businesses that have a known exposure to PFAS. Others are pressing boards for timelines for phase-out and disclosure. Reputational risk may be underestimated by the market. The Truth About Forever Chemicals, a BBC Panorama documentary, exposed viewers to pictures of polluted water systems in Britain. Seeing families talk about the chemicals found in their blood gives a human touch to what could otherwise be a compliance problem.
This is part of a larger pattern. There have been safety shortcuts in aviation. Opioid lawsuits against pharmaceutical companies were far more numerous than anticipated. The social cost of engagement algorithms is a problem for tech companies. PFAS seems to be the turn of the chemical industry. Early warnings appeared, were discussed, were occasionally mute, and then reappeared with interest—financial interest—in each instance.
Citing crises linked to nature and the climate, the European Central Bank has issued a warning about growing financial system fragility. Awkwardly, PFAS fits into that frame. Chemical contamination spreads erratically and manifests itself years later in soil samples or medical research, in contrast to carbon, which can be estimated and priced using emissions scenarios. Measurable risk is preferred by investors. Forever chemicals are difficult to model neatly.
The issue of disclosure is another. Shareholders may file claims against publicly traded companies that do not disclose material PFAS exposure. The reasoning is straightforward: costs associated with litigation and remediation should be included in filings if they are predictable. However, businesses frequently operate in regulatory gray areas, claiming that standards are changing. Whether courts will accept that ambiguity as a defense is still up in the air.
The tangible proof is subtle outside of factories. No black clouds belching from smoke stacks. No spectacular oil spills. Just unseen molecules that are quietly building up and resisting disintegration. It’s possible that this invisibility contributed to the crisis’s delayed recognition. Despite its lofty goals, ESG often focuses on measurable indicators like carbon intensity, board diversity percentages, and installed renewable capacity. Such neat dashboards are resistant to PFAS.
An uncomfortable recalibration is now required of investors. Instead of responding to risk, ESG was designed to foresee it. Blind spots may still exist, as evidenced by the rise of forever chemicals as a common liability. There is a perception that “sustainable” portfolios might still include legacy hazards that were present decades ago, when regulatory oversight was laxer and chemical innovation outpaced toxicology.
This does not imply that all exposed businesses are doomed. Some are increasing transparency, investing in alternatives, and phased out PFAS. Active participation might lessen the damage and possibly even rebuild confidence. However, trust takes time to restore after it has been damaged.
One gets the impression from watching this develop that Wall Street’s relationship with ESG is changing in unsettling ways. The focus is changing from aspiration to accountability, from branding to liability. That change has been compelled by persistent and unyielding chemicals. Additionally, they are here to stay, unlike quarterly earnings.
